Neurology and therapy - JoVE Visualize

Showing results (571-580 of 942) with videos related to

Pageof 95

Sort By:

Neurology and Therapy|May 19, 2026

Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAETaoufik Alsaadi, Reem Suliman, Ahsan H Khandoker, et al.

Neurology and Therapy|May 23, 2026

Real-World Safety and Effectiveness of Lasmiditan in Patients with Migraine: A Post-Marketing Observational Study in JapanNaoko Sanno, Kevin Y Urayama, Joji Mori, et al.

Neurology and Therapy|May 24, 2026

Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) RiskSilvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, et al.

Neurology and Therapy|May 24, 2026

Safety and Efficacy of Obinutuzumab β (MIL62), a Novel Glycoengineered Type II Anti-CD20 Monoclonal Antibody, in Patients with Neuromyelitis Optica Spectrum Disorder: A Multicenter, Single-Arm, Phase Ib Clinical TrialLei Wu, Min Wei, Feng Gao, et al.

Neurology and Therapy|December 2, 2020

Parent Experiences of Sanfilippo Syndrome Impact and Unmet Treatment Needs: A Qualitative AssessmentKatherine Ackerman Porter, Cara O'Neill, Elise Drake, et al.

Neurology and Therapy|June 5, 2026

Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims AnalysisNing Cheng, Annaliza Dominguez, Shivaji R Manthena, et al.

Neurology and Therapy|June 5, 2026

A Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing-Remitting Multiple SclerosisClair-Antoine Veyrier, Patrick Vermersch, Olivier Casez, et al.

Neurology and Therapy|May 1, 2026

Understanding the Unmet Needs of People with MS at Diagnosis and Throughout Their Care Journey: Insights from a Survey-Based StudyKlaus Schmierer, Pieter van Galen, Helen Gray, et al.

Neurology and Therapy|April 30, 2026

A Multimodal Latent Severity Axis for Alzheimer's Disease: Probabilistic PCA, Bayesian Trajectories, and Stage-Aware Timing EffectsBabak Haji, Amir Abbas Tahami Monfared,

Neurology and Therapy|April 10, 2026

Treatment Effects on Chronic Active Lesions in Multiple Sclerosis: Current Evidence and Future PerspectivesPaolo Preziosa, Giorgio Guido, Massimo Filippi, et al.

Pageof 95

Showing results (571-580 of 942) with videos related to

Sort By:

Pageof 95

Neurology and Therapy|May 19, 2026

Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAETaoufik Alsaadi, Reem Suliman, Ahsan H Khandoker, et al.

Neurology and Therapy|May 23, 2026

Real-World Safety and Effectiveness of Lasmiditan in Patients with Migraine: A Post-Marketing Observational Study in JapanNaoko Sanno, Kevin Y Urayama, Joji Mori, et al.

Neurology and Therapy|May 24, 2026

Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) RiskSilvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, et al.

Neurology and Therapy|May 24, 2026

Safety and Efficacy of Obinutuzumab β (MIL62), a Novel Glycoengineered Type II Anti-CD20 Monoclonal Antibody, in Patients with Neuromyelitis Optica Spectrum Disorder: A Multicenter, Single-Arm, Phase Ib Clinical TrialLei Wu, Min Wei, Feng Gao, et al.

Neurology and Therapy|December 2, 2020

Parent Experiences of Sanfilippo Syndrome Impact and Unmet Treatment Needs: A Qualitative AssessmentKatherine Ackerman Porter, Cara O'Neill, Elise Drake, et al.

Neurology and Therapy|June 5, 2026

Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims AnalysisNing Cheng, Annaliza Dominguez, Shivaji R Manthena, et al.

Neurology and Therapy|June 5, 2026

A Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing-Remitting Multiple SclerosisClair-Antoine Veyrier, Patrick Vermersch, Olivier Casez, et al.

Neurology and Therapy|May 1, 2026

Understanding the Unmet Needs of People with MS at Diagnosis and Throughout Their Care Journey: Insights from a Survey-Based StudyKlaus Schmierer, Pieter van Galen, Helen Gray, et al.

Neurology and Therapy|April 30, 2026

A Multimodal Latent Severity Axis for Alzheimer's Disease: Probabilistic PCA, Bayesian Trajectories, and Stage-Aware Timing EffectsBabak Haji, Amir Abbas Tahami Monfared,

Neurology and Therapy|April 10, 2026

Treatment Effects on Chronic Active Lesions in Multiple Sclerosis: Current Evidence and Future PerspectivesPaolo Preziosa, Giorgio Guido, Massimo Filippi, et al.

Pageof 95